PR Newswire Clinical TrialsOriginal article
AOB Pharma and Biorasi to Partner to run Phase 2b in Moderate to Severe Acne
PartnershipPositive
AI Analysis
Summary
AOB Pharma partners with Biorasi to advance Phase 2b trial for moderate to severe acne ahead of schedule while maintaining its global Phase 3 atopic dermatitis program timeline.
Clinical Trial Data
Phase
2b
Outcome Details
AOB Pharma and Biorasi partnership to conduct Phase 2b trial in moderate to severe acne
Importance:7/10
Sentiment:
0.60
partnershipphase_2bacneatopic_dermatitisclinical_trialtrial_acceleration
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on July 1, 2026 6:37 PM